Oral azoxystrobin driving the dynamic change in resistome by disturbing the stability of the gut microbiota of Enchytraeus crypticus

2021 ◽  
pp. 127252
Author(s):  
Qi Zhang ◽  
Yitian Yu ◽  
Mingkang Jin ◽  
Yu Deng ◽  
Bingyu Zheng ◽  
...  
2021 ◽  
Vol 14 (8) ◽  
pp. 733
Author(s):  
Julia Aresti-Sanz ◽  
Markus Schwalbe ◽  
Rob Rodrigues Pereira ◽  
Hjalmar Permentier ◽  
Sahar El Aidy

Methylphenidate is one of the most widely used oral treatments for attention-deficit/hyperactivity disorder (ADHD). The drug is mainly absorbed in the small intestine and has low bioavailability. Accordingly, a high interindividual variability in terms of response to the treatment is known among ADHD patients treated with methylphenidate. Nonetheless, very little is known about the factors that influence the drug’s absorption and bioavailability. Gut microbiota has been shown to reduce the bioavailability of a wide variety of orally administered drugs. Here, we tested the ability of small intestinal bacteria to metabolize methylphenidate. In silico analysis identified several small intestinal bacteria to harbor homologues of the human carboxylesterase 1 enzyme responsible for the hydrolysis of methylphenidate in the liver into the inactive form, ritalinic acid. Despite our initial results hinting towards possible bacterial hydrolysis of the drug, up to 60% of methylphenidate is spontaneously hydrolyzed in the absence of bacteria and this hydrolysis is pH-dependent. Overall, our results indicate that the stability of methylphenidate is compromised under certain pH conditions in the presence or absence of gut microbiota.


2019 ◽  
Vol 13 (5) ◽  
pp. 256-260
Author(s):  
Naoyoshi Nagata ◽  
Mari Tohya ◽  
Fumihiko Takeuchi ◽  
Wataru Suda ◽  
Suguru Nishijima ◽  
...  

2019 ◽  
Vol 55 (61) ◽  
pp. 8935-8938 ◽  
Author(s):  
Nizar Akermi ◽  
Hela Mkaouar ◽  
Aicha Kriaa ◽  
Amin Jablaoui ◽  
Souha Soussou ◽  
...  

Eubacterium saburreum serpin from human gut microbiota inhibits the pancreatic elastase associated with pancreatitis, inhibition is strongly increased by para-sulphonato-calix[8]arene silver nanoparticles.


2014 ◽  
Vol 2014 ◽  
pp. 1-10 ◽  
Author(s):  
Botao Qin ◽  
Yi Lu ◽  
Fanglei Li ◽  
Yuwei Jia ◽  
Chao Zhu ◽  
...  

Inorganic solidified foam (ISF) is a novel material for preventing coal fires. This paper presents the preparation process and working principle of main installations. Besides, aqueous foam with expansion ratio of 28 and 30 min drainage rate of 13% was prepared. Stability of foam fluid was studied in terms of stability coefficient, by varying water-slurry ratio, fly ash replacement ratio of cement, and aqueous foam volume alternatively. Light microscope was utilized to analyze the dynamic change of bubble wall of foam fluid and stability principle was proposed. In order to further enhance the stability of ISF, different dosage of calcium fluoroaluminate was added to ISF specimens whose stability coefficient was tested and change of hydration products was detected by scanning electron microscope (SEM). The outcomes indicated that calcium fluoroaluminate could enhance the stability coefficient of ISF and compact hydration products formed in cell wall of ISF; naturally, the stability principle of ISF was proved right. Based on above-mentioned experimental contents, ISF with stability coefficient of 95% and foam expansion ratio of 5 was prepared, which could sufficiently satisfy field process requirements on plugging air leakage and thermal insulation.


2020 ◽  
Author(s):  
Chunlin Yin ◽  
Xue Liu ◽  
Hongxia Wang ◽  
Mingcong Yan ◽  
Lijuan Guo ◽  
...  

Abstract Background: Urotensin II (UII) is involved in the formation of atherosclerosis, but its role in the stability of atherosclerotic plaque is undetermined. The purpose of this study was to observe the dynamic change of plasma UII and analyze its relationship with the stability of atherosclerotic plaques. Methods: The plasma UII concentration in patients with acute coronary syndrome (ACS) was detected. A vulnerable plaque model was established by local transfection of a recombinant P53 adenovirus into plaques of rabbits fed with a high-cholesterol diet and subjected to balloon injury, to evaluate the stability of the atherosclerotic plaques. Results: Our results showed that the level of plasma UII was increased in ACS patients compared with healthy subjects. However, it was significantly decreased in ST-segment elevation myocardial infarction patients (STEMI) and increased again in acute myocardial infarction (AMI) patients that were discharged after three months. UII dynamic change and its correlation with plaques stabilities were further verified in rabbit with atherosclerotic vulnerable plaque. The UII level in rabbits was significantly decreased after P53 gene transfection which can lead to of plaque instability. Conclusions: In conclusion, the level of plasma UII was significantly decreased in ACS with STEMI, which may serve as a reliable biological marker to reflect the progression and stability of atherosclerotic plaques.


2020 ◽  
Vol 256 ◽  
pp. 113463 ◽  
Author(s):  
Jun Ma ◽  
Qing-Lin Chen ◽  
Patrick O’Connor ◽  
G. Daniel Sheng

1999 ◽  
Vol 121 (4) ◽  
pp. 606-614 ◽  
Author(s):  
S. A. Jensen ◽  
Y. C. Shin

This paper presents rigorous experimental validation results of the stability algorithm as developed in the Part I. The two experiments which will be presented here focus on; first, a workpiece whose vibrational modes constitute the weakest part of the overall system, and second, a machine tool whose vibrational modes are the weakest part of the system. Next, it discusses some of the influencing factors that affect the onset of chatter in face milling processes. The factors considered include cutting conditions, entry and exit angles, axial dynamics, cutter geometry, material properties and structural dynamic parameters. Lastly, it presents the effect of structural dynamic change under operating condition on stability lobes.


2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Guo-Jie Brandon-Mong ◽  
Grace Tzun-Wen Shaw ◽  
Wei-Hsin Chen ◽  
Chien-Chang Chen ◽  
Daryi Wang

Abstract Background Neuropathic pain is an abnormally increased sensitivity to pain, especially from mechanical or thermal stimuli. To date, the current pharmacological treatments for neuropathic pain are still unsatisfactory. The gut microbiota reportedly plays important roles in inducing neuropathic pain, so probiotics have also been used to treat it. However, the underlying questions around the interactions in and stability of the gut microbiota in a spared nerve injury-induced neuropathic pain model and the key microbes (i.e., the microbes that play critical roles) involved have not been answered. We collected 66 fecal samples over 2 weeks (three mice and 11 time points in spared nerve injury-induced neuropathic pain and Sham groups). The 16S rRNA gene was polymerase chain reaction amplified, sequenced on a MiSeq platform, and analyzed using a MOTHUR- UPARSE pipeline. Results Here we show that spared nerve injury-induced neuropathic pain alters gut microbial diversity in mice. We successfully constructed reliable microbial interaction networks using the Metagenomic Microbial Interaction Simulator (MetaMIS) and analyzed these networks based on 177,147 simulations. Interestingly, at a higher resolution, our results showed that spared nerve injury-induced neuropathic pain altered both the stability of the microbial community and the key microbes in a gut micro-ecosystem. Oscillospira, which was classified as a low-abundance and core microbe, was identified as the key microbe in the Sham group, whereas Staphylococcus, classified as a rare and non-core microbe, was identified as the key microbe in the spared nerve injury-induced neuropathic pain group. Conclusions In summary, our results provide novel experimental evidence that spared nerve injury-induced neuropathic pain reshapes gut microbial diversity, and alters the stability and key microbes in the gut.


2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Yasmina Ait Chait ◽  
Walid Mottawea ◽  
Thomas A. Tompkins ◽  
Riadh Hammami

Abstract Over the past decade, there has been increasing evidence highlighting the implication of the gut microbiota in a variety of brain disorders such as depression, anxiety, and schizophrenia. Studies have shown that depression affects the stability of gut microbiota, but the impact of antidepressant treatments on microbiota structure and metabolism remains underexplored. In this study, we investigated the in vitro antimicrobial activity of antidepressants from different therapeutic classes against representative strains of human gut microbiota. Six different antidepressants: phenelzine, venlafaxine, desipramine, bupropion, aripiprazole and (S)-citalopram have been tested for their antimicrobial activity against 12 commensal bacterial strains using agar well diffusion, microbroth dilution method, and colony counting. The data revealed an important antimicrobial activity (bacteriostatic or bactericidal) of different antidepressants against the tested strains, with desipramine and aripiprazole being the most inhibitory. Strains affiliating to most dominant phyla of human microbiota such as Akkermansia muciniphila, Bifidobacterium animalis and Bacteroides fragilis were significantly altered, with minimum inhibitory concentrations (MICs) ranged from 75 to 800 μg/mL. A significant reduction in bacterial viability was observed, reaching 5 logs cycle reductions with tested MICs ranged from 400 to 600 μg/mL. Our findings demonstrate that gut microbiota could be altered in response to antidepressant drugs.


Sign in / Sign up

Export Citation Format

Share Document